NTRK1 and prostate carcinoma: Interestingly, five pathways, the Notch signaling pathway, receptor tyrosine kinase/PDGF signaling pathway, TGF-β signaling pathway, VEGFA signaling pathway, and Wnt signaling pathway, were in common in both S:E fusion-positive and T:E fusion-positive prostate cancers (Figure S2B).